Receive returns under control
A returned product is not automatically saleable. Record, identify and block it before deciding its status. Review condition, origin, reason for return and evidence of storage and transport conditions. Evidence of cold-chain continuity is particularly important for refrigerated medicines.
Document any return to saleable stock
A qualified decision considers every applicable criterion. Visual checks cannot replace missing temperature records or an unclear supply chain. Follow an approved process for returning stock to saleable inventory. Unsuitable products stay blocked and undergo controlled handling.
Connect recall records with physical stock
Product, batch and recipient data must enable targeted searches. The recall procedure covers contact availability, communication, stock reconciliation and a final report. Check effectiveness regularly, at least annually under EU GDP for human medicines. A documented exercise with a selected batch helps evaluate readiness.
Handle complaints and suspected falsification
Distinguish quality complaints from distribution issues and document their handling. Secure products when falsification is credibly suspected and inform the relevant authority and marketing authorisation holder as required. Blocked products must not be accidentally picked or returned without control.
Prepare for site planning
The planning lists below are practical recommendations for your site project; they do not replace project-specific qualification or a regulatory decision.
- Provide returns and recall zones
- Link batches, suppliers and recipients
- Define authority for return-to-stock decisions
- Maintain recall contacts and cover arrangements
- Document exercises, reconciliation and closure